- Primary Citation Not Available
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Generic NameRisperidoneProduct NameRISPERDAL®Therapeutic AreaBehaviors and Mental DisordersEnrollment303% Female39.5%% White98%
Product ClassAtypical AntipsychoticsSponsor Protocol NumberRISSCH4043Data PartnerJohnson & JohnsonCondition StudiedSchizophreniaMean/Median Age (Years)30.6
- Collected Datasets Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- Temporal trajectories of side-effects associated with antipsychotic treatment ? An individual participant data meta-analysis
- Harnessing clinical trial data to inform real-world clinical decision making in the treatment of schizophrenia
- Inflammation and the Metabolic Syndrome in Psychosis
- Machine Learning for predicting treatment efficacy and clinical categorizations across mental health disorders.